tert-Butyl piperazine-1-carboxylate → HCID 69038776, compound
Reaction equation
Cl[C:2]1[N:3]=[N:4][CH:5]=[C:6]([C:8]([F:11])([F:10])[F:9])[CH:7]=1.[C:12]([O:16][C:17]([N:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1)=[O:18])([CH3:15])([CH3:14])[CH3:13]>CC(N(C)C)=O.C(OCC)(=O)C>[C:12]([O:16][C:17]([N:19]1[CH2:24][CH2:23][N:22]([C:2]2[N:3]=[N:4][CH:5]=[C:6]([C:8]([F:11])([F:10])[F:9])[CH:7]=2)[CH2:21][CH2:20]1)=[O:18])([CH3:15])([CH3:13])[CH3:14]Participants
5
Conditions
- Temperature
- 100 °C
Procedure
3-Chloro-5-trifluoromethyl-pyridazine (200 mg) was added to piperazine-1-carboxylic acid tert-butyl ester (231 mg) in dimethylacetamide (3 mL), and the reaction mixture was stirred at 100° C. for 3 hours. After such time, the reaction mixture was allowed to cool down to room temperature and diluted with ethyl acetate. The solid was filtered off and washed with ethyl acetate. The filtrate was then concentrated in vacuo and then purified by column chromatography (SiO2, Heptane/EtOAc) to yield the title compound as a white solid (364 mg). MS (m/e): 333.4 (M+H+, 100%)
Workup
- temperatureto cool down to room temperature
- filtrationThe solid was filtered off
- washwashed with ethyl acetate
- concentrationThe filtrate was then concentrated in vacuo
- custompurified by column chromatography (SiO2, Heptane/EtOAc)
Sources & evidence
- ORD record
- ord-4b01918a6d614bcca7fed21ecd2f1887
- Source dataset
- uspto-grants-2009_10
- Patent number
- US07605163B2
Reaction notes
Loading…